LE Magazine May 2002

Page 1 of 4
Breast cancer/vitamin E
Does lack of tocopherols and
tocotrienols put women at increased risk of breast cancer?
Breast cancer is the leading site of new cancers in women
and the second leading cause (after lung cancer) of cancer
mortality in women. Observational studies that have collected
data for dietary exposure to alpha-tocopherol with or without
the other related tocopherols and tocotrienols have suggested
that vitamin E from dietary sources may provide women with
modest protection from breast cancer. However, there is no
evidence that vitamin E supplements confer any protection
whatever against breast cancer. Observational studies that
have assessed exposure to vitamin E by plasma or adipose
tissue concentrations of alpha-tocopherol have failed to
provide consistent support for the idea that alpha-tocopherol
provides any protection against breast cancer. In addition,
evidence from studies in experimental animals suggest that
alpha-tocopherol supplementation alone has little effect on
mammary tumors. In contrast, studies in breast cancer cells
indicate that alpha- gamma-, and delta-tocotrienol, and to a
lesser extent delta-tocopherol, have potent antiproliferative
and proapoptotic effects that would be expected to reduce risk
of breast cancer. Many vegetable sources of alpha-tocopherol
also contain other tocopherols or tocotrienols. Thus, it seems
plausible that the modest protection from breast cancer
associated with dietary vitamin E may be due to the effects of
the other tocopherols and the tocotrienols in the diet.
Additional studies will be required to determine whether this
may be the case, and to identify the most active
tocopherol/tocotrienol.
J Nutr Biochem 2002
Jan;13(1):2-20
Diet and the risk of breast cancer in
a case-control study: does the threat of disease have an
influence on recall bias?
It has been suggested that recall bias may explain the
discrepant results between case-control and cohort studies on
diet and the risk of breast cancer. Two control groups were
used for this case-control study of 25 to 75-year-old breast
cancer cases (n = 310). The first group consisted of
population controls drawn from the Finnish National Population
Register (n = 454). The second group consisted of women who
were referred to the same examinations as were the cases
because of clinical suspicion of breast disease but who were
later diagnosed as healthy (referral controls; n = 506).
Because the diagnosis was unknown at the time of interview, it
was possible to assess by comparing the two control groups
whether the self-reporting of diet changed under the threat of
disease. Dietary habits were examined using a validated,
self-administered food-frequency questionnaire. Premenopausal
women misreported their consumption of liquid milk products,
tea and sugar. Reporting bias was also associated with the
intake of fat and vitamins. Postmenopausal women misreported
consumption of milk products. When recall bias was taken into
consideration, milk was associated with increased risk of
premenopausal breast cancer, whereas high consumption of
poultry or high intake of monounsaturated fatty acids, n-3
fatty acids, n-6 fatty acids and vitamin E were related to
lower risk. The study suggested that oil, milk, cheese, coffee
and beta-carotene may act as protective factors in
postmenopausal women, whereas butter and cream may be risk
factors for breast cancer. In summary, it is possible that
some food items may be overreported or underreported under the
threat of disease in health-conscious population. However,
most of the results in this study were not modified by recall
bias.
J Clin Epidemiol 1999
May;52(5):429-39
Interaction of family history of
breast cancer and dietary antioxidants with breast cancer risk
(New York, United States).
We sought to determine if specific dietary antioxidants may
be particularly effective in reducing breast cancer risk for
women reporting family history (FH) of breast cancer in a
first-degree relative. Interviews regarding usual diet, health
and family histories were conducted with 262 premenopausal and
371 postmenopausal women with incident, primary breast cancer
from western New York (United States). These women were
frequency-matched by age and county of residence with
community controls. Among premenopausal women, there was a
significant interaction between FH and alpha-tocopherol;
alpha-tocopherol was associated with significantly decreased
risk among FH+ women (adjusted fourth-quartile odds ratio [OR]
= 0.01, 95 percent confidence interval [CI] = 0.0-0.3). This
association was much weaker for FH- women [OR = 0.7, CI =
0.4-1.2]. For FH- women, a significant inverse association was
observed between beta-carotene and premenopausal breast-cancer
risk (OR = 0.4, CI = 0.3-0.5), but not for FH+ women (OR =
0.5, CI = 0.1-4.0). Similar relationships, although not as
strong, were noted among postmenopausal women. Although
limited by small numbers, these results suggest that biologic
mechanisms of tumorigenesis may differ in FH+ and FH- women,
and that alpha-tocopherol may be a potential chemopreventive
agent for women with a family history of breast cancer,
particularly premenopausal women.
Cancer Causes Control 1995
Sep;6(5):407-15
Premenopausal breast cancer risk and
intake of vegetables, fruits and related nutrients.
BACKGROUND: Given the international variations in breast
cancer incidence rates and the changes in breast cancer
incidence among migrant populations, it has been hypothesized
that diet is a factor influencing risk of this disease. Many
studies indicate that a diet high in vegetables and fruits may
protect against breast cancer. PURPOSE: We conducted a
case-control study of diet, including the intake of non-food
supplements, and premenopausal breast cancer risk. We
evaluated in detail usual intake of vegetables and fruits
(each measured as the total reported grams consumed for all
queried vegetables and fruit), vitamins C and E, folic acid,
individual carotenoids and dietary fiber with its components.
METHODS: Case patients (n=297) were identified through
pathology records from hospitals in Erie and Niagara counties
in western New York. They consisted of premenopausal women 40
years of age or oder who were diagnosed with breast cancer
from November 1986 through April 1991. Control subjects
(n=311), frequency-matched to case patients on the basis of
age and county of residence, were randomly selected from New
York State Department of Motor Vehicles records. In-person
interviews included detailed reports of usual diet in the
period 2 years before the interview. Unconditional logistic
regression was used to estimate odds ratios (ORs) and 95%
confidence intervals (CIs). RESULTS: There was a reduction in
risk associated with high intake of several nutrients. With
the lowest quartile of intake as the referent, adjusted ORs
for the highest quartile of intake for specific nutrients were
as follows: vitamin C (OR=0.53; 95% CI=0.33-0.86),
alpha-tocopheral (OR=0.55; 95% CI=0.34-0.88), folic acid
(OR=0.50; 95% CI=0.31-0.82), alpha-carotene (OR=0.67; 95%
CI=0.42-1.08) and beta-carotene (OR=0.46; 95% CI=0.28-0.74),
lutein + zeaxanthin (OR=0.47; 95% CI=0.28.0-77), and dietary
fiber from vegetables and fruits (OR=0.48; 95% CI=0.30-0.78).
No association with risk was found for beta-cryptoxanthin,
lycopene, or grain fiber. Fruits were weakly associated with a
reduction in risk (fourth quartile OR=0.67; 95% CI=0.42-1.09).
No association was found between breast cancer risk and intake
of vitamins C and E and folic acid taken as supplements. A
strong inverse association between total vegetable intake and
risk was observed (fourth quartile OR=0.46; 95% CI=0.28-0.74).
This inverse association was found to be independent of
vitamin C,alpha-tocopherol, folic acid, dietary fiber, and
alpha-carotene. Adjusting for beta-carotene or lutein +
zeaxanthin somewhat attenuated the inverse association with
vegetable intake. CONCLUSIONS: In this population, intake of
vegetables appears to decrease premenopausal breast cancer
risk. This effect may be related, in part, to beta-carotene
and lutein + zeaxanthin in vegetables. It appears, however,
that, of the nutrients and food components examined, no single
dietary factor explains the effect. Evaluated components found
together in vegetables may have a synergistic effect on breast
cancer risk; alternatively, other unmeasured factors in these
foods may also influence risk.
J Natl Cancer Inst 1996 Mar
20;88(6):340-8
The role of fat, animal protein and
some vitamin consumption in breast cancer: a case control
study in southern France.
The role of the consumption of fat, animal protein and
vitamins on breast-cancer risk was investigated in a
hospital-based case-control study of 924 patients (409 cases
and 515 controls) in Montpellier (France). A dietary history
questionnaire, administered by interview, comprising 55 key
food items as well as beverage consumption, and including food
frequencies and portion sizes, was used to measure the intake
of total fat and its constituents, animal protein, retinol,
beta-carotene, vitamin E and alcohol consumption. The
questionnaire also elicited information on relevant medical
history and personal characteristics. All food items which
showed significantly elevated odds ratio (high-fat cheese,
desserts and chocolate and processed pork meat) in a
multivariate analysis contained a high proportion of animal
fat. This is reflected in the nutrient analysis, which showed
a significant linear trend as well as an elevated odds ratio
for the highest tertile of consumption of total fat [OR3 = 1.6
(1.1-2.2)], animal fat [OR3 = 1.6 (1.1-2.2)], saturated fat
[OR3 = 1.9 (1.3-2.6)] and mono-unsaturated fat [OR3 = 1.7
(1.2-2.5)]. For post-menopausal women, there is a particularly
strong association with saturated fat [OR3 = 3.3 (1.4-7.8)] in
a multivariate analysis including all other significant
nutrients. There is no evidence of an increase of risk with
the intake of animal protein and no evidence of risk reduction
with increased consumption of vegetables, beta-carotene or
vitamin E. Along with some recent studies, our results give
support to the hypothesis that dietary fat is a risk factor in
breast carcinogenesis.
Int J Cancer 1991 Apr
22;48(1):1-9\
Continued on Page 2 of
4
Back to
the Magazine Forum
|
LE Magazine May 2002

Page 2 of 4
Efficacy of the various forms of vitamin
E
Effects of tocotrienols on life span
and protein carbonylation in Caenorhabditis elegans.
To assess the efficiency of tocotrienols against oxidative
damage, we have demonstrated in a model-system nematode,
Caenorhabditis elegans, that tocotrienol administration
reduced the accumulation of protein carbonyl (a good indicator
of oxidative damage during aging) and consequently extended
the mean life span (LS), but not the maximum LS. Conversely,
alpha-tocopherol acetate did not affect these parameters. As a
way to evaluate the protective ability of tocotrienols against
oxidative stress, the life spans of animals administrated
tocotrienols before or after exposure to ultraviolet B-induced
oxidative stress were measured. Ultraviolet B irradiation
shortened the mean LS of animals, whereas preadministration of
tocotrienols recovered the mean LS to that of unirradiated
animals. Interestingly, postadministration also extended the
mean LS more than that of unirradiated animals, and
administration through the LS conferred greater protection.
Thus, the administration of tocotrienols to animals results in
a reduction of oxidative stress risks. These data indicated
that tocotrienols merit further investigation as possible
agents for antiaging and oxidative stress prevention. In
addition, they suggest that C. elegans will continue to
provide provocative clues into the mechanisms of aging.
J Gerontol A Biol Sci Med Sci 2000
Jun;55(6):B280-5
Effects of vitamin E on lipid
peroxidation in healthy persons.
CONTEXT: Oxidative stress may play a role in the
development or exacerbation of many common diseases. However,
results of prospective controlled trials of the effects of
antioxidants such as vitamin E are contradictory. OBJECTIVE:
To assess the effects of supplemental vitamin E on lipid
peroxidation in vivo in healthy adults. DESIGN: Randomized,
double-blind, placebo-controlled trial conducted March 1999 to
June 2000. SETTING: A general clinical research center in a
tertiary referral academic medical center. PARTICIPANTS:
Thirty healthy men and women aged 18 to 60 years.
INTERVENTIONS: Participants were randomly assigned to receive
placebo or alpha-tocopherol dosages of 200, 400, 800, 1200 or
2000 IU/d for 8 weeks (n = 5 in each group), followed by an
8-week washout period. MAIN OUTCOME MEASURES: Three indices of
lipid peroxidation, urinary 4-hydroxynonenal (4-HNE) and 2
isoprostanes, iPF(2alpha)-III and iPF(2alpha)-VI, measured by
gas vs 168 (22.3) pg/mg of creatinine for subjects taking
placebo; 165 (19.6) vs 234 (30.1) pg/mg for those taking 200
IU/d of vitamin E; and 195 (26.7) vs 213 (40.6) pg/mg for
subjects taking 2000 IU/d. Corresponding iPF(2alpha)-VI levels
were 1.43 (0.6) vs 1.62 (0.4) ng/mg of creatinine for subjects
taking placebo; 1.64 (0.3) vs 1.24 (0.8) ng/mg for those
taking 200 IU/d of vitamin E; and 1.83 (0.3) vs 1.94 (0.9)
ng/mg for those taking 2000 IU/d. Baseline vs week 8 levels of
4-HNE were 0.5 (0.04) vs 0.4 (0.05) ng/mg of creatinine for
subjects taking placebo; 0.4 (0.06) vs 0.5 (0.02) ng/mg with
200 IU/d of vitamin E; and 0.2 (0.02) vs 0.2 (0.1) ng/mg with
2000 IU/d. CONCLUSIONS: Our results question the rationale for
vitamin E supplementation in healthy individuals. Specific
quantitative indices of oxidative stress in vivo should be
considered as entry criteria and for dose selection in
clinical trials of antioxidant drugs and vitamins in human
disease.
JAMA 2001 Mar 7;285(9):1178-82
Antioxidant effects of tocotrienols in
patients with hyperlipidemia and carotid stenosis.
Antioxidants may have a role in the prevention of
atherosclerosis. In the present trial, we investigated the
antioxidant properties of Palm Vitee, a gamma-tocotrienol-,
and alpha-tocopherol enriched fraction of palm oil, in
patients with carotid atherosclerosis. Serum lipids, fatty
acid peroxides, platelet aggregation and carotid artery
stenosis were measured over an 18-month period in fifty
patients with cerebrovascular disease. Change in stenosis was
measured with duplex ultrasonography. Ultrasound scans were
done at six months, twelve months, and yearly thereafter.
Bilateral duplex ultrasonography revealed apparent carotid
atherosclerotic regression in seven and progression in two of
the 25 tocotrienol patients, while none of the control group
exhibited regression and ten of 25 showed progression (P <
0.002). Serum thiobarbituric acid reactive substances, an ex
vivo indicator of maximal platelet peroxidation, decreased in
the treatment group from 1.08 +/- 0.70 to 0.80 +/- 0.55
microM/L (P < 0.05) after 12 mon, and in the placebo group,
they increased nonsignificantly from 0.99 +/- 0.80 to 1.26 +/-
0.54 microM/L. Both tocotrienol and placebo groups displayed
significantly attenuated collagen-induced platelet aggregation
responses (P < 0.05) as compared with entry values. Serum
total cholesterol, low density lipoprotein cholesterol, and
triglyceride values remained unchanged in both groups, as did
the plasma high density lipoprotein cholesterol values. These
findings suggest that antioxidants, such as tocotrienols, may
influence the course of carotid atherosclerosis.
Lipids 1995 Dec;30(12):1179-83
Dietary antioxidant vitamins and death
from coronary heart disease in postmenopausal women.
BACKGROUND: The role of dietary antioxidant vitamins in
preventing coronary heart disease has aroused considerable
interest because of the knowledge that oxidative modification
of low-density lipoprotein may promote atherosclerosis.
METHODS. We studied 34,486 postmenopausal women with no
cardiovascular disease who in early 1986 completed a
questionnaire that assessed, among other factors, their intake
of vitamins A, E and C from food sources and supplements.
During approximately seven years of follow-up (ending December
31, 1992), 242 of the women died of coronary heart disease.
RESULTS. In analyses adjusted for age and dietary energy
intake, vitamin E consumption appeared to be inversely
associated with the risk of death from coronary heart disease.
This association was particularly striking in the subgroup of
21,809 women who did not consume vitamin supplements (relative
risks from lowest to highest quintile of vitamin E intake,
1.0, 0.68, 0.71, 0.42 and 0.42; P for trend 0.008). After
adjustment for possible confounding variables, this inverse
association remained (relative risks from lowest to highest
quintile, 1.0, 0.70, 0.76, 0.32 and 0.38; P for trend, 0.004).
There was little evidence that the intake of vitamin E from
supplements was associated with a decreased risk of death from
coronary heart disease, but the effects of high-dose
supplementation and the duration of supplement use could not
be definitely addressed. Intake of vitamins A and C did not
appear to be associated with the risk of death form coronary
heart disease. CONCLUSIONS. These results suggest that in
postmenopausal women the intake of vitamin E from food is
inversely associated with the risk of death from coronary
heart disease and that such women can lower their risk without
using vitamin supplements. By contrast, the intake of vitamins
A and C was not associated with lower risks of dying from
coronary disease.
N Engl J Med 1996 May
2;334(18):1156-62
Apoptosis and cell-cycle arrest in
human and murine tumor cells are initiated by isoprenoids.
Diverse classes of phytochemicals initiate biological
responses that effectively lower cancer risk. One class of
phytochemicals, broadly defined as pure and mixed isoprenoids,
encompasses an estimated 22,000 individual components. A
representative mixed isoprenoid, gamma-tocotrienol, suppresses
the growth of murine B16(F10) melanoma cells, and with greater
potency, the growth of human breast adenocarcinoma (MCF-7) and
human leukemic (HL-60) cells. beta-Ionone, a pure isoprenoid,
suppresses the growth of B16 cells and with greater potency,
the growth of MCF-7, HL-60 and human colon adenocarcinoma
(Caco-2) cells. Results obtained with diverse cell lines
differing in ras and p53 status showed that the
isoprenoid-mediated suppression of growth is independent of
mutated ras and p53 functions. beta-Ionone suppressed the
growth of human colon fibroblasts (CCD-18Co) but only when
present at three-fold the concentration required to suppress
the growth of Caco-2 cells. The isoprenoids initiated
apoptosis and, concomitantly arrested cells in the G1 phase of
the cell cycle. Both suppress 3-hydroxy-3-methylglutaryl CoA
reductase activity. beta-Ionone and lovastatin interfered with
the posttranslational processing of lamin B, an activity
essential to assembly of daughter nuclei. This interference,
we postulate, renders neosynthesized DNA available to the
endonuclease activities leading to apoptotic cell death.
Lovastatin-imposed mevalonate starvation suppressed the
glycosylation and translocation of growth factor receptors to
the cell surface. As a consequence, cells were arrested in the
G1 phase of the cell cycle. This rationale may apply to the
isoprenoid-mediated G1-phase arrest of tumor cells. The
additive and potentially synergistic actions of these
isoprenoids in the suppression of tumor cell proliferation and
initiation of apoptosis coupled with the mass action of the
diverse isoprenoid constituents of plant products may explain,
in part, the impact of fruit, vegetable and grain consumption
on cancer risk.
J Nutr 1999 Apr;129(4):804-13
Macular degeneration
Identification and quantitation of
carotenoids and their metabolites in the tissues of the human
eye.
There is increasing evidence that the macular pigment
carotenoids, lutein and zeaxanthin, may play an important role
in the prevention of age-related macular degeneration,
cataract, and other blinding disorders. Although it is well
known that the retina and lens are enriched in these
carotenoids, relatively little is known about carotenoid
levels in the uveal tract and in other ocular tissues. Also,
the oxidative metabolism and physiological functions of the
ocular carotenoids are not fully understood. Thus, we have set
out to identify and quantify the complete spectrum of dietary
carotenoids and their oxidative metabolites in a systematic
manner in all tissues of the human eye in order to gain better
insight into their ocular physiology. Human donor eyes were
dissected, and carotenoid extracts from ocular tissues
[retinal pigment epithelium/choroid (RPE/choroid), macula,
peripheral retina, ciliary body, iris, lens, vitreous, cornea,
and sclera] were analyzed by high-performance liquid
chromatography (HPLC). Carotenoids were identified and
quantified by comparing their chromatographic and spectral
profiles with those of authentic standards. Nearly all ocular
structures examined with the exception of vitreous, cornea,
and sclera had quantifiable levels of dietary
(3R,3'R,6'R)-lutein, zeaxanthin, their geometrical (E / Z)
isomers, as well as their metabolites, (3R,3'S,6'R)-lutein
(3'-epilutein) and 3-hydroxy-beta,epsilon-caroten-3'-one. In
addition, human ciliary body revealed the presence of
monohydroxycarotenoids and hydrocarbon carotenoids, while only
the latter group was detected in human RPE/choroid. Uveal
structures (iris, ciliary body, and RPE/choroid) account for
approximately 50% of the eyes total carotenoids and
approximately 30% of the lutein and zeaxanthin. In the iris,
these pigments are likely to play a role in filtering out
phototoxic short-wavelength visible light, while they are more
likely to act as antioxidants in the ciliary body. Both
mechanisms, light screening and antioxidant, may be operative
in the RPE/choroid in addition to a possible function of this
tissue in the transport of dihydroxycarotenoids from the
circulating blood to the retina. This report lends further
support for the critical role of lutein, zeaxanthin, and other
ocular carotenoids in protecting the eye from light-induced
oxidative damage and aging.
Exp Eye Res 2001 Mar;72(3):215-23
Continued on Page 3 of
4
Back to
the Magazine Forum
|
LE Magazine May 2002

Page 3 of 4
Influence of lutein supplementation on
macular pigment, assessed with two objective techniques.
PURPOSE: Macular pigment (MP) may protect against
age-related macular degeneration. This study was conducted to
determine the extent of changes in the macular pigment density
as a consequence of oral supplementation with lutein. A second
purpose was to compare two objective measurement techniques.
METHODS: In the first technique, reflectance maps were made
with a scanning laser ophthalmoscope. Digital subtraction of
log reflectance maps and comparison between the foveal area
and a 14 degrees temporal site provided MP density estimates.
In the second technique, spectral fundus reflectance of the
fovea was measured with a fundus reflectometer and analyzed
with a detailed optical model, to arrive at MP density values.
Eight subjects participated in this study. They took 10 mg
lutein per day for 12 weeks. Plasma lutein concentration was
measured at 4-week intervals. RESULTS: After 4 weeks, mean
blood level of lutein had increased from 0.18 to 0.90 microM.
It stayed at this level throughout the intake period and
declined to 0.28 microM 4 weeks after termination. Measurement
of the density of MP showed a within-subject variation of 10%
with MP maps and 17% with spectral reflectance analysis. MP
density showed a mean linear 4-week increase of 5.3% (P: <
0.001) and 4.1% (P: = 0. 022), respectively. CONCLUSIONS:
Supplementation with lutein significantly increased the
density of the MP. Analyzing reflectance maps with a scanning
laser ophthalmoscope provided very reliable estimates of
MP.
Invest Ophthalmol Vis Sci 2000
Oct;41(11):3322-6
Lutein and zeaxanthin concentrations
in rod outer segment membranes from perifoveal and peripheral
human retina.
PURPOSE: In addition to acting as an optical filter,
macular (carotenoid) pigment has been hypothesized to function
as an antioxidant in the human retina by inhibiting the
peroxidation of long-chain polyunsaturated fatty acids.
However, at its location of highest density in the inner
(prereceptoral) layers of the foveal retina, a specific
requirement for antioxidant protection would not be predicted.
The purpose of this study was to determine whether lutein and
zeaxanthin, the major carotenoids comprising the macular
pigment, are present in rod outer segment (ROS) membranes
where the concentration of long-chain polyunsaturated fatty
acids, and susceptibility to oxidation, is highest. METHODS:
Retinas from human donor eyes were dissected to obtain two
regions: an annular ring of 1.5- to 4-mm eccentricity
representing the area centralis excluding the fovea
(perifoveal retina) and the remaining retina outside this
region (peripheral retina). ROS and residual (ROS-depleted)
retinal membranes were isolated from these regions by
differential centrifugation and their purity checked by
polyacrylamide gel electrophoresis and fatty acid analysis.
Lutein and zeaxanthin were analyzed by high-performance liquid
chromatography and their concentrations expressed relative to
membrane protein. Preparation of membranes and analysis of
carotenoids were performed in parallel on bovine retinas for
comparison to a nonprimate species. Carotenoid concentrations
were also determined for retinal pigment epithelium harvested
from human eyes. RESULTS: ROS membranes prepared from
perifoveal and peripheral regions of human retina were found
to be of high purity as indicated by the presence of a dense
opsin band on protein gels. Fatty acid analysis of human ROS
membranes showed a characteristic enrichment of
docosahexaenoic acid relative to residual membranes. Membranes
prepared from bovine retinas had protein profiles and fatty
acid composition similar to those from human retinas.
Carotenoid analysis showed that lutein and zeaxanthin were
present in ROS and residual human retinal membranes. The
combined concentration of lutein plus zeaxanthin was 70%
higher in human ROS than in residual membranes. Lutein plus
zeaxanthin in human ROS membranes was 2.7 times more
concentrated in the perifoveal than the peripheral retinal
region. Lutein and zeaxanthin were consistently detected in
human retinal pigment epithelium at relatively low
concentrations. CONCLUSIONS: The presence of lutein and
zeaxanthin in human ROS membranes raises the possibility that
they function as antioxidants in this cell compartment. The
finding of a higher concentration of these carotenoids in ROS
of the perifoveal retina lends support to their proposed
protective role in age-related macular degeneration.
Invest Ophthalmol Vis Sci 2000
Apr;41(5):1200-9
The role of oxidative stress in the
pathogenesis of age-related macular degeneration.
Age-related macular degeneration (AMD) is the leading cause
of blind registration in the developed world, and yet its
pathogenesis remains poorly understood. Oxidative stress,
which refers to cellular damage caused by reactive oxygen
intermediates (ROI), has been implicated in many disease
processes, especially age-related disorders. ROIs include free
radicals, hydrogen peroxide, and singlet oxygen, and they are
often the byproducts of oxygen metabolism. The retina is
particularly susceptible to oxidative stress because of its
high consumption of oxygen, its high proportion of
polyunsaturated fatty acids, and its exposure to visible
light. In vitro studies have consistently shown that
photochemical retinal injury is attributable to oxidative
stress and that the antioxidant vitamins A, C, and E protect
against this type of injury. Furthermore, there is strong
evidence suggesting that lipofuscin is derived, at least in
part, from oxidatively damaged photoreceptor outer segments
and that it is itself a photoreactive substance. However, the
relationships between dietary and serum levels of the
antioxidant vitamins and age-related macular disease are less
clear, although a protective effect of high plasma
concentrations of alpha-tocopherol has been convincingly
demonstrated. Macular pigment is also believed to limit
retinal oxidative damage by absorbing incoming blue light
and/or quenching ROIs. Many putative risk-factors for AMD have
been linked to a lack of macular pigment, including female
gender, lens density, tobacco use, light iris color and
reduced visual sensitivity. Moreover, the Eye Disease
Case-Control Study found that high plasma levels of lutein and
zeaxanthin were associated with reduced risk of neovascular
AMD. The concept that AMD can be attributed to cumulative
oxidative stress is enticing, but remains unproven. With a
view to reducing oxidative damage, the effect of nutritional
antioxidant supplements on the onset and natural course of
age-related macular disease is currently being evaluated.
Surv Ophthalmol 2000
Sep-Oct;45(2):115-34
Protein oxidation and loss of protease
activity may lead to cataract formation in the aged lens.
Over 95% of the dry mass of the eye lens consists of
specialized proteins called crystallins. Aged lenses are
subject to cataract formation, in which damage, cross-linking,
and precipitation of crystallins contribute to a loss of lens
clarity. Cataract is one of the major causes of blindness, and
it is estimated that over 50,000,000 people suffer from this
disability. Damage to lens crystallins appears to be largely
attributable to the effects of UV radiation and/or various
active oxygen species (oxygen radicals, 1O2, H2O2, etc.).
Photooxidative damage to lens crystallins is normally retarded
by a series of antioxidant enzymes and compounds. Crystallins
which experience mild oxidative damage are rapidly degraded by
a system of lenticular proteases. However, extensive oxidation
and cross-linking severely decrease proteolytic susceptibility
of lens crystallins. Thus, in the young lens the combination
of antioxidants and proteases serves to prevent crystallin
damage and precipitation in cataract formation. The aged lens,
however, exhibits diminished antioxidant capacity and
decreased proteolytic capabilities. The loss of proteolytic
activity may actually be partially attributable to oxidative
damage which proteases (like any other protein) can sustain.
We propose that the rate of crystallin damage increases as
antioxidant capacity declines with age. The lower protease
activity of aged lens cells may be insufficient to cope with
such rates of crystallin damage, and denatured crystallins may
begin to accumulate. As the concentration of oxidatively
denatured crystallins rises, cross-linking reactions may
produce insoluble aggregates which are refractive to protease
digestion. Such a scheme could explain many events which are
known to contribute to cataract formation, as well as several
which have appeared to be unrelated.
Free Radic Biol Med
1987;3(6):371-7
Macular pigment optical density in a
midwestern sample.
OBJECTIVE: To assess the distribution of the macular
pigments (MPs) lutein (L) and zeaxanthin (Z) in a healthy
sample more representative of the general population than past
studies and to determine which dietary factors and personal
characteristics might explain the large interindividual
differences in the density of these MPs. DESIGN: Prevalence
study in a self-selected population. PARTICIPANTS: Two hundred
eighty healthy adult volunteers, consisting of 138 men and 142
women, between the ages of 18 and 50 years, recruited from the
general population. METHODS: MP optical density was measured
psychophysically at 460 nm by use of a 1 degrees test field.
Serum was analyzed for carotenoid and vitamin E content with
reversed-phase high-performance liquid chromatography. Usual
intakes of nutrients over the past year were determined by
means of a food frequency questionnaire. MAIN OUTCOME
MEASURES: MP optical density. RESULTS: Mean MP optical density
measured 0.211 +/- 0.13, which is approximately 40% lower than
the average reported in smaller, less representative studies.
MP density was 44% lower in the bottom versus the top quintile
of serum L and Z concentrations. Similarly, MP density was 33%
lower in the bottom compared with the top quintile of L and Z
intake. MP density was 19% lower in blue-grey-eyed subjects
than in subjects with brown-black irises. When all variables
were considered together in a general linear model of
determinants of MP, statistically significant (P < 0.05)
relationships were found between MP density and serum L and Z,
dietary L and Z intake, fiber intake, and iris color.
CONCLUSIONS: These data suggest that MP values in this healthy
adult population are lower than in smaller select samples.
Moreover, these data indicate that MP is related to serum L
and Z, dietary L and Z intake, fiber intake, and iris
color.
Ophthalmology 2001
Apr;108(4):730-7
The potential role of dietary
xanthophylls in cataract and age-related macular
degeneration.
The carotenoid xanthophylls, lutein and zeaxanthin,
accumulate in the eye lens and macular region of the retina.
Lutein and zeaxanthin concentrations in the macula are greater
than those found in plasma and other tissues. A relationship
between macular pigment optical density, a marker of lutein
and zeaxanthin concentration in the macula, and lens optical
density, an antecedent of cataractous changes, has been
suggested. The xanthophylls may act to protect the eye from
ultraviolet phototoxicity via quenching reactive oxygen
species and/or other mechanisms. Some observational studies
have shown that generous intakes of lutein and zeaxanthin,
particularly from certain xanthophyll-rich foods like spinach,
broccoli and eggs, are associated with a significant reduction
in the risk for cataract (up to 20%) and for age-related
macular degeneration (up to 40%). While the pathophysiology of
cataract and age-related macular degeneration is complex and
contains both environmental and genetic components, research
studies suggest dietary factors including antioxidant vitamins
and xanthophylls may contribute to a reduction in the risk of
these degenerative eye diseases. Further research is necessary
to confirm these observations.
J Am Coll Nutr 2000 Oct;19(5
Suppl):522S-527S
Continued on Page 4 of
4
Back to
the Magazine Forum
|
LE Magazine May 2002

Page 4 of 4
Prostate Cancer
U.S. dietary exposures to heterocyclic
amines.
Heterocyclic amines (HAs) formed in fried, broiled or
grilled meats are potent mutagens that increase rates of
colon, mammary, prostate and other cancers in bioassay
rodents. Studies of how human dietary HA exposures may affect
cancer risks have so far relied on fairly crudely defined
HA-exposure categories. Recently, an integrated, quantitative
approach to HA-exposure assessment (HAEA) was developed to
estimate compound-specific intakes for particular individuals
based on corresponding HA-concentration estimates that reflect
their meat-type, intake-rate, cooking-method and meat-doneness
preferences. This method was applied in the present study to
U.S. national Continuing Survey of Food Intakes by Individuals
(CSFII) data on meats consumed and cooking methods used by
>25,000 people, after adjusting for underreported energy
intake and conditional on meat-doneness preferences estimated
from additional survey data. The U.S. population average
lifetime time-weighted average of total HAs consumed was
estimated to be approximately 9 ng/kg/day, with
2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)
estimated to comprise about two thirds of this intake.
Pan-fried meats were the largest source of HA in the diet and
chicken the largest source of HAs among different meat types.
Estimated total HA intakes by male vs. female children were
generally similar, with those by (0- to 15-year-old) children
approximately 25% greater than those by (16+-year-old) adults.
Race-, age- and sex-specific mean HA intakes were estimated to
be greatest for African American males, who were estimated to
consume approximately 2- and approximately 3-fold more PhIP
than white males at ages <16 and 30+ years, respectively,
after considering a relatively greater preference for more
well-done items among African Americans based on national
survey data. This difference in PhIP intakes may at least
partly explain why prostate cancer (PC) kills approximately
2-fold more African American than white men, in view of
experimental data indicating that PhIP mutates prostate DNA
and causes prostate tumors in rats.
J Expo Anal Environ Epidemiol 2001
May-Jun;11(3):155-68
Indole-3-carbinol (I3C) induced cell
growth inhibition, G1 cell cycle arrest and apoptosis in
prostate cancer cells.
Prostate cancer is one of the most common cancers in men
and it is the second leading cause of cancer related death in
men in the United States. Recent dietary and epidemiological
studies have suggested the benefit of dietary intake of fruits
and vegetables in lowering the incidence of prostate cancer. A
diet rich in fruits and vegetables provides phytochemicals,
particularly indole-3-carbinol (I3C), which may be responsible
for the prevention of many types of cancer, including
hormone-related cancers such as prostate. Studies to elucidate
the role and the molecular mechanism(s) of action of I3C in
prostate cancer, however, have not been conducted. In the
current study, we investigated whether I3C had any effect
against prostate cancer cells and, if so, attempts were made
to identify the potential molecular mechanism(s) by which I3C
elicits its biological effects on prostate cancer cells. Here
we report for the first time that I3C inhibits the growth of
PC-3 prostate cancer cells. Induction of G1 cell cycle arrest
was also observed in PC-3 cells treated with I3C, which may be
due to the observed effects of I3C in the up-regulation of
p21(WAF1) and p27(Kip1) CDK inhibitors, followed by their
association with cyclin D1 and E and down-regulation of CDK6
protein kinase levels and activity. The induction of p21(WAF1)
appears to be transcriptionally upregulated and independent of
the p53 responsive element. In addition, I3C inhibited the
hyperpohosphorylation of the Retinoblastoma (Rb) protein in
PC-3 cells. Induction of apoptosis was also observed in this
cell line when treated with I3C, as measured by DNA laddering
and poly (ADP-ribose) polymersae (PARP) cleavage. We also
found an up-regulation of Bax, and down-regulation of Bcl-2 in
I3C-treated cells. These effects may also be mediated by the
down-regulation of NF-kappaB observed in I3C treated PC-3
cells. From these results, we conclude that I3C inhibits the
growth of PC-3 prostate cancer cells by inducing G1 cell cycle
arrest leading to apoptosis, and regulates the expression of
apoptosis-related genes. These findings suggest that I3C may
be an effective chemopreventive or therapeutic agent against
prostate cancer.
Oncogene 2001 May
24;20(23):2927-36
Fruit and vegetable intakes and
prostate cancer risk.
BACKGROUND: There is extensive and consistent evidence that
high fruit and vegetable intakes are associated with decreased
risks of many cancers, but results for prostate cancer risk
have been inconsistent. We studied the associations of fruit
and vegetable intakes with prostate cancer risk in a
population-based, case-control study of men under 65 years of
age. METHODS: Case participants were 628 men from King County
(Seattle area), WA, who were newly diagnosed with prostate
cancer. Control participants were 602 men recruited from the
same underlying population and frequency matched to case
participants by age. Self-administered food-frequency
questionnaires were used to assess diet over the 3- to 5-year
period before diagnosis or recruitment. Daily nutrient intakes
were calculated by use of a nutrient database with recently
updated analytic values for carotenoids. Odds ratios for
prostate cancer risk associated with foods and nutrients were
calculated by use of unconditional logistic regression.
RESULTS: No associations were found between fruit intake and
prostate cancer risk. The adjusted odds ratio (ORs) for the
comparison of 28 or more servings of vegetables per week with
fewer than 14 servings per week was 0.65 (95% confidence
interval [CI] = 0.45-0.94), with a two-sided P for trend =.01.
For cruciferous vegetable consumption, adjusted for covariates
and total vegetable intake, the OR for comparison of three or
more servings per week with less than one serving per week was
0.59 (95% CI = 0.39-0.90), with a two-sided P for trend =.02.
The OR for daily intake of 2000 microg or more lutein plus
zeaxanthin compared with an intake of less than 800 microg was
0.68 (95% CI = 0.45-1.00). CONCLUSION: These results suggest
that high consumption of vegetables, particularly cruciferous
vegetables, is associated with a reduced risk of prostate
cancer.
J Natl Cancer Inst 2000 Jan
5;92(1):61-8
Mechanisms of anti-carcinogenesis by
indole-3-carbinol. Studies of enzyme induction,
electrophile-scavenging, and inhibition of aflatoxin B1
activation.
The induction of oxidation and conjugation enzymes, the
scavenging of carcinogen electrophiles, and the inhibition of
aflatoxin B1 (AFB1) activation were examined as possible
mechanisms of anti-carcinogenesis by indole-3-carbinol (I3C).
Liver microsomal 7-ethoxycoumarin O-deethylase and
7-ethoxyresorufin O-deethylase activities were not induced
significantly in rainbow trout fed diets containing 500-2000
ppm I3C for 8 days compared to trout fed the control diet.
Furthermore, no detectable changes in the specific contents of
cytochrome P-450 isozymes LM2 and LM4b, as measured by
Western-blotting and immunoquantitation, were found in liver
microsomes following dietary I3C administration. Dietary I3C
had no significant effect on liver microsomal uridine
diphosphate-glucuronyl-transferase activity, measured using
the substrates 1-naphthol and testosterone, or on cytosolic
glutathione S-transferase activity, measured using the
substrate styrene oxide. The ability of I3C or its acid
reaction products (RXM; generated by the reaction of I3C with
HCl) to act as scavengers for the direct alkylating agent
AFB1-8,9-Cl2 was examined. Addition of I3C or RXM to in vitro
incubations did not inhibit the covalent binding of
AFB1-8,9-Cl2 to calf thymus DNA. Kinetic analyses of
microsome-mediated binding of AFB1 to DNA in vitro indicated
that RXM inhibited the metabolic activation of AFB1. RXM
increased the apparent Km for the AFB1-DNA binding reaction
without changing the associated Vmax; the apparent Km values
at 0, 3.5, 35, and 350 microM RXM were 35, 38, 66 and 86
microM for trout liver microsomes. RXM also inhibited the
activation of AFB1 by rat liver microsomes, but I3C was not an
effective inhibitor against AFB1-DNA binding mediated by
either rat or trout liver microsomes. The results of the
present study indicate that inhibition of microsome-activated
AFB1 binding to DNA by I3C products may be of significant
importance in I3C inhibition of hepatocarcinogenesis in trout
and other species. The inhibition of carcinogen activation by
I3C is contrasted with the mechanism of anti-carcinogenesis by
beta-naphthoflavone, which involves induction of xenobiotic
metabolizing enzymes.
Biochem Pharmacol 1990 Jan
1;39(1):19-26
A prospective study of dietary fat and
risk of prostate cancer.
BACKGROUND: The strong correlation between national
consumption of fat and national rate of mortality from
prostate cancer has raised the hypothesis that dietary fat
increases the risk of this malignancy. Case-control and cohort
studies have not consistently supported this hypothesis.
PURPOSE: We examined prospectively the relationship between
prostate cancer and dietary fat, including specific fatty
acids and dietary sources of fat. We examined the relationship
of fat consumption to the incidence of advanced prostate
cancer (stages C, D or fatal cases) and to the total incidence
of prostate cancer. METHODS: We used data from the Health
Professionals Follow-up Study, which is a prospective cohort
of 51529 U.S. men, aged 40 through 75, who completed a
validated food-frequency questionnaire in 1986. We sent
follow-up questionnaires to the entire cohort in 1988 and 1990
to document new cases of a variety of diseases and to update
exposure information. As of January 31, 1990, 300 new cases of
prostate cancer, including 126 advanced cases, were documented
in 47855 participants initially free of diagnosed cancer. The
Mantel-Haenszel summary estimator was used to adjust for age
and other potentially confounding variables. Multiple logistic
regression was used to estimate relative risks (RRs) when
controlling simultaneously for more than two covariates.
RESULTS: Total fat consumption was directly related to risk of
advanced prostate cancer (age- and energy-adjusted RR = 1.79,
with 95% confidence interval [CI] = 1.04-3.07, for high versus
low quintile of intake; P [trend] = .06). This association was
due primarily to animal fat (RR = 1.63; 95% CI = 0.95-2.78; P
[trend] = .08), but not vegetable fat. Red meat represented
the food group with the strongest positive association with
advanced cancer (RR = 2.64; 95% CI = 1.21-5.77; P = .02). Fat
from dairy products (with the exception of butter) or fish was
unrelated to risk. Saturated fat, monounsaturated fat, and
alpha-linolenic acid, but not linoleic acid, were associated
with advanced prostate cancer risk; only the association with
alpha-linolenic acid persisted when saturated fat,
monounsaturated fat, linoleic acid, and alpha-linolenic acid
were modeled simultaneously (multivariate RR = 3.43; 95% CI =
1.67-7.04; P [trend] = .002). CONCLUSION: The results support
the hypothesis that animal fat, especially fat from red meat,
is associated with an elevated risk of advanced prostate
cancer. IMPLICATIONS: These findings support recommendations
to lower intake of meat to reduce the risk of prostate cancer.
The potential roles of carcinogens formed in cooking animal
fat and of alpha-linolenic acid in the progression of prostate
cancer need to be explored.
J Natl Cancer Inst 1993 Oct
6;85(19):1571-9
Nutritional and socioeconomic factors
in relation to prostate cancer mortality: a cross-national
study.
BACKGROUND: Large international variations in rates of
prostate cancer incidence and mortality suggest that
environmental factors have a strong influence on the
development of this disease. The purpose of this study was to
identify predictive variables for prostate cancer mortality in
data from 59 countries. METHODS: Data on prostate cancer
mortality, food consumption, tobacco use, socioeconomic
factors, reproductive factors, and health indicators were
obtained from United Nations sources. Linear regression models
were fit to these data. The influence of each variable fit in
the regression models was assessed by multiplying the
regression coefficient b by the 75th (X75) and 25th (X25)
percentile values of the variable. The difference, bX75 -
bX25, is the estimated effect of the variable across its
interquartile range on mortality rates measured as deaths per
100000 males aged 45 to 74 years. Reported P values are
two-sided. RESULTS: Prostate cancer mortality was inversely
associated with estimated consumption of cereals (bX75 - bX25
= -7.31 deaths; P = .001), nuts and oilseeds (bX75 - bX25 =
-1.72 deaths; P = .003), and fish (bX75 - bX25 = -1.47 deaths;
P = .001). In the 42 countries for which we had appropriate
data, soy products were found to be significantly protective
(P = .0001), with an effect size per kilocalorie at least four
times as large as that of any other dietary factor. Besides
variables related to diet, we observed an association between
prostate cancer mortality rates and a composite of other
health-related, sanitation, and economic variables (P = .003).
CONCLUSIONS: The specific food-related results from this study
are consistent with previous information and support the
current dietary guidelines and hypothesis that grains,
cereals, and nuts are protective against prostate cancer. The
findings also provide a rationale for future study of soy
products in prostate cancer prevention trials.
J Natl Cancer Inst 1998 Nov
4;90(21):1637-47
Back to
the Magazine Forum
|
|
|